 | • レポートコード：MRC2Q12-16840 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| コロナ禍により、反復拡張障害治療剤の世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に反復拡張障害治療剤のグローバル市場のxxx％を占める「経口」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院薬局」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 反復拡張障害治療剤の中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの反復拡張障害治療剤市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 反復拡張障害治療剤のグローバル主要プレイヤーには、Pfizer, Inc.、CRISPR Therapeutics、Acorda Therapeutics、Capsida Biotherapeutics Inc.、Larimar Therapeutics, Inc.、Healx, Intellia Therapeutics, Inc.、Editas Medicine、Bluebird bio, Inc.、Sanofi, Merck & Co., Inc.、H. Lundbeck A/S、Cellectis SA、Bio-Techne、GlaxoSmithKline plc、Allergan Aurobindo Pharma Ltd.、Sun Pharmaceutical Industries Ltd.、Torrent Pharmaceuticals Ltd.、Intas Pharmaceuticals Ltd.、Cipla Ltdなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 反復拡張障害治療剤市場は、種類と用途によって区分されます。世界の反復拡張障害治療剤市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 経口、注射 【用途別セグメント】 病院薬局、小売店薬局、オンライン薬局 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 反復拡張障害治療剤製品概要 - 種類別市場（経口、注射） - 用途別市場（病院薬局、小売店薬局、オンライン薬局） - 調査の目的 ・エグゼクティブサマリー - 世界の反復拡張障害治療剤販売量予測2017-2028 - 世界の反復拡張障害治療剤売上予測2017-2028 - 反復拡張障害治療剤の地域別販売量 - 反復拡張障害治療剤の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別反復拡張障害治療剤販売量 - 主要メーカー別反復拡張障害治療剤売上 - 主要メーカー別反復拡張障害治療剤価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（経口、注射） - 反復拡張障害治療剤の種類別販売量 - 反復拡張障害治療剤の種類別売上 - 反復拡張障害治療剤の種類別価格 ・用途別市場規模（病院薬局、小売店薬局、オンライン薬局） - 反復拡張障害治療剤の用途別販売量 - 反復拡張障害治療剤の用途別売上 - 反復拡張障害治療剤の用途別価格 ・北米市場 - 北米の反復拡張障害治療剤市場規模（種類別、用途別） - 主要国別の反復拡張障害治療剤市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの反復拡張障害治療剤市場規模（種類別、用途別） - 主要国別の反復拡張障害治療剤市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の反復拡張障害治療剤市場規模（種類別、用途別） - 主要国別の反復拡張障害治療剤市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の反復拡張障害治療剤市場規模（種類別、用途別） - 主要国別の反復拡張障害治療剤市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの反復拡張障害治療剤市場規模（種類別、用途別） - 主要国別の反復拡張障害治療剤市場規模（トルコ、サウジアラビア） ・企業情報 Pfizer, Inc.、CRISPR Therapeutics、Acorda Therapeutics、Capsida Biotherapeutics Inc.、Larimar Therapeutics, Inc.、Healx, Intellia Therapeutics, Inc.、Editas Medicine、Bluebird bio, Inc.、Sanofi, Merck & Co., Inc.、H. Lundbeck A/S、Cellectis SA、Bio-Techne、GlaxoSmithKline plc、Allergan Aurobindo Pharma Ltd.、Sun Pharmaceutical Industries Ltd.、Torrent Pharmaceuticals Ltd.、Intas Pharmaceuticals Ltd.、Cipla Ltd ・産業チェーン及び販売チャネル分析 - 反復拡張障害治療剤の産業チェーン分析 - 反復拡張障害治療剤の原材料 - 反復拡張障害治療剤の生産プロセス - 反復拡張障害治療剤の販売及びマーケティング - 反復拡張障害治療剤の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 反復拡張障害治療剤の産業動向 - 反復拡張障害治療剤のマーケットドライバー - 反復拡張障害治療剤の課題 - 反復拡張障害治療剤の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Repeat Expansion Disorders Treatment estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Repeat Expansion Disorders Treatment is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Repeat Expansion Disorders Treatment is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Repeat Expansion Disorders Treatment is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Repeat Expansion Disorders Treatment include Pfizer, Inc., CRISPR Therapeutics, Acorda Therapeutics, Capsida Biotherapeutics Inc., Larimar Therapeutics, Inc., Healx, Intellia Therapeutics, Inc., Editas Medicine, Bluebird bio, Inc. and Sanofi, Merck & Co., Inc., etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Repeat Expansion Disorders Treatment companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Repeat Expansion Disorders Treatment market. Further, it explains the major drivers and regional dynamics of the global Repeat Expansion Disorders Treatment market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Pfizer, Inc.
CRISPR Therapeutics
Acorda Therapeutics
Capsida Biotherapeutics Inc.
Larimar Therapeutics, Inc.
Healx, Intellia Therapeutics, Inc.
Editas Medicine
Bluebird bio, Inc.
Sanofi, Merck & Co., Inc.
H. Lundbeck A/S
Cellectis SA
Bio-Techne
GlaxoSmithKline plc
Allergan Aurobindo Pharma Ltd.
Sun Pharmaceutical Industries Ltd.
Torrent Pharmaceuticals Ltd.
Intas Pharmaceuticals Ltd.
Cipla Ltd
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Repeat Expansion Disorders Treatment Segment by Type
Oral
Injection
Repeat Expansion Disorders Treatment Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Repeat Expansion Disorders Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Repeat Expansion Disorders Treatment market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Repeat Expansion Disorders Treatment, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Repeat Expansion Disorders Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Repeat Expansion Disorders Treatment revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Repeat Expansion Disorders Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Repeat Expansion Disorders Treatment revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Inc., CRISPR Therapeutics, Acorda Therapeutics, Capsida Biotherapeutics Inc., Larimar Therapeutics, Inc., Healx, Intellia Therapeutics, Inc., Editas Medicine, Bluebird bio, Inc. and Sanofi, Merck & Co., Inc., etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Repeat Expansion Disorders Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Repeat Expansion Disorders Treatment companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Repeat Expansion Disorders Treatment revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Repeat Expansion Disorders Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Repeat Expansion Disorders Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Repeat Expansion Disorders Treatment Market Perspective (2017-2028)
2.2 Repeat Expansion Disorders Treatment Growth Trends by Region
2.2.1 Repeat Expansion Disorders Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Repeat Expansion Disorders Treatment Historic Market Size by Region (2017-2022)
2.2.3 Repeat Expansion Disorders Treatment Forecasted Market Size by Region (2023-2028)
2.3 Repeat Expansion Disorders Treatment Market Dynamics
2.3.1 Repeat Expansion Disorders Treatment Industry Trends
2.3.2 Repeat Expansion Disorders Treatment Market Drivers
2.3.3 Repeat Expansion Disorders Treatment Market Challenges
2.3.4 Repeat Expansion Disorders Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Repeat Expansion Disorders Treatment Players by Revenue
3.1.1 Global Top Repeat Expansion Disorders Treatment Players by Revenue (2017-2022)
3.1.2 Global Repeat Expansion Disorders Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Repeat Expansion Disorders Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Repeat Expansion Disorders Treatment Revenue
3.4 Global Repeat Expansion Disorders Treatment Market Concentration Ratio
3.4.1 Global Repeat Expansion Disorders Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Repeat Expansion Disorders Treatment Revenue in 2021
3.5 Repeat Expansion Disorders Treatment Key Players Head office and Area Served
3.6 Key Players Repeat Expansion Disorders Treatment Product Solution and Service
3.7 Date of Enter into Repeat Expansion Disorders Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Repeat Expansion Disorders Treatment Breakdown Data by Type
4.1 Global Repeat Expansion Disorders Treatment Historic Market Size by Type (2017-2022)
4.2 Global Repeat Expansion Disorders Treatment Forecasted Market Size by Type (2023-2028)
5 Repeat Expansion Disorders Treatment Breakdown Data by Application
5.1 Global Repeat Expansion Disorders Treatment Historic Market Size by Application (2017-2022)
5.2 Global Repeat Expansion Disorders Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Repeat Expansion Disorders Treatment Market Size (2017-2028)
6.2 North America Repeat Expansion Disorders Treatment Market Size by Type
6.2.1 North America Repeat Expansion Disorders Treatment Market Size by Type (2017-2022)
6.2.2 North America Repeat Expansion Disorders Treatment Market Size by Type (2023-2028)
6.2.3 North America Repeat Expansion Disorders Treatment Market Share by Type (2017-2028)
6.3 North America Repeat Expansion Disorders Treatment Market Size by Application
6.3.1 North America Repeat Expansion Disorders Treatment Market Size by Application (2017-2022)
6.3.2 North America Repeat Expansion Disorders Treatment Market Size by Application (2023-2028)
6.3.3 North America Repeat Expansion Disorders Treatment Market Share by Application (2017-2028)
6.4 North America Repeat Expansion Disorders Treatment Market Size by Country
6.4.1 North America Repeat Expansion Disorders Treatment Market Size by Country (2017-2022)
6.4.2 North America Repeat Expansion Disorders Treatment Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Repeat Expansion Disorders Treatment Market Size (2017-2028)
7.2 Europe Repeat Expansion Disorders Treatment Market Size by Type
7.2.1 Europe Repeat Expansion Disorders Treatment Market Size by Type (2017-2022)
7.2.2 Europe Repeat Expansion Disorders Treatment Market Size by Type (2023-2028)
7.2.3 Europe Repeat Expansion Disorders Treatment Market Share by Type (2017-2028)
7.3 Europe Repeat Expansion Disorders Treatment Market Size by Application
7.3.1 Europe Repeat Expansion Disorders Treatment Market Size by Application (2017-2022)
7.3.2 Europe Repeat Expansion Disorders Treatment Market Size by Application (2023-2028)
7.3.3 Europe Repeat Expansion Disorders Treatment Market Share by Application (2017-2028)
7.4 Europe Repeat Expansion Disorders Treatment Market Size by Country
7.4.1 Europe Repeat Expansion Disorders Treatment Market Size by Country (2017-2022)
7.4.2 Europe Repeat Expansion Disorders Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Repeat Expansion Disorders Treatment Market Size (2017-2028)
8.2 Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Type
8.2.1 Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Repeat Expansion Disorders Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Application
8.3.1 Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Repeat Expansion Disorders Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Region
8.4.1 Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Repeat Expansion Disorders Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Repeat Expansion Disorders Treatment Market Size (2017-2028)
9.2 Latin America Repeat Expansion Disorders Treatment Market Size by Type
9.2.1 Latin America Repeat Expansion Disorders Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Repeat Expansion Disorders Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Repeat Expansion Disorders Treatment Market Share by Type (2017-2028)
9.3 Latin America Repeat Expansion Disorders Treatment Market Size by Application
9.3.1 Latin America Repeat Expansion Disorders Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Repeat Expansion Disorders Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Repeat Expansion Disorders Treatment Market Share by Application (2017-2028)
9.4 Latin America Repeat Expansion Disorders Treatment Market Size by Country
9.4.1 Latin America Repeat Expansion Disorders Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Repeat Expansion Disorders Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Repeat Expansion Disorders Treatment Market Size (2017-2028)
10.2 Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Type
10.2.1 Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Repeat Expansion Disorders Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Application
10.3.1 Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Repeat Expansion Disorders Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Country
10.4.1 Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Repeat Expansion Disorders Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Company Details
11.1.2 Pfizer, Inc. Business Overview
11.1.3 Pfizer, Inc. Repeat Expansion Disorders Treatment Introduction
11.1.4 Pfizer, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.1.5 Pfizer, Inc. Recent Developments
11.2 CRISPR Therapeutics
11.2.1 CRISPR Therapeutics Company Details
11.2.2 CRISPR Therapeutics Business Overview
11.2.3 CRISPR Therapeutics Repeat Expansion Disorders Treatment Introduction
11.2.4 CRISPR Therapeutics Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.2.5 CRISPR Therapeutics Recent Developments
11.3 Acorda Therapeutics
11.3.1 Acorda Therapeutics Company Details
11.3.2 Acorda Therapeutics Business Overview
11.3.3 Acorda Therapeutics Repeat Expansion Disorders Treatment Introduction
11.3.4 Acorda Therapeutics Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.3.5 Acorda Therapeutics Recent Developments
11.4 Capsida Biotherapeutics Inc.
11.4.1 Capsida Biotherapeutics Inc. Company Details
11.4.2 Capsida Biotherapeutics Inc. Business Overview
11.4.3 Capsida Biotherapeutics Inc. Repeat Expansion Disorders Treatment Introduction
11.4.4 Capsida Biotherapeutics Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.4.5 Capsida Biotherapeutics Inc. Recent Developments
11.5 Larimar Therapeutics, Inc.
11.5.1 Larimar Therapeutics, Inc. Company Details
11.5.2 Larimar Therapeutics, Inc. Business Overview
11.5.3 Larimar Therapeutics, Inc. Repeat Expansion Disorders Treatment Introduction
11.5.4 Larimar Therapeutics, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.5.5 Larimar Therapeutics, Inc. Recent Developments
11.6 Healx, Intellia Therapeutics, Inc.
11.6.1 Healx, Intellia Therapeutics, Inc. Company Details
11.6.2 Healx, Intellia Therapeutics, Inc. Business Overview
11.6.3 Healx, Intellia Therapeutics, Inc. Repeat Expansion Disorders Treatment Introduction
11.6.4 Healx, Intellia Therapeutics, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.6.5 Healx, Intellia Therapeutics, Inc. Recent Developments
11.7 Editas Medicine
11.7.1 Editas Medicine Company Details
11.7.2 Editas Medicine Business Overview
11.7.3 Editas Medicine Repeat Expansion Disorders Treatment Introduction
11.7.4 Editas Medicine Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.7.5 Editas Medicine Recent Developments
11.8 Bluebird bio, Inc.
11.8.1 Bluebird bio, Inc. Company Details
11.8.2 Bluebird bio, Inc. Business Overview
11.8.3 Bluebird bio, Inc. Repeat Expansion Disorders Treatment Introduction
11.8.4 Bluebird bio, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.8.5 Bluebird bio, Inc. Recent Developments
11.9 Sanofi, Merck & Co., Inc.
11.9.1 Sanofi, Merck & Co., Inc. Company Details
11.9.2 Sanofi, Merck & Co., Inc. Business Overview
11.9.3 Sanofi, Merck & Co., Inc. Repeat Expansion Disorders Treatment Introduction
11.9.4 Sanofi, Merck & Co., Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.9.5 Sanofi, Merck & Co., Inc. Recent Developments
11.10 H. Lundbeck A/S
11.10.1 H. Lundbeck A/S Company Details
11.10.2 H. Lundbeck A/S Business Overview
11.10.3 H. Lundbeck A/S Repeat Expansion Disorders Treatment Introduction
11.10.4 H. Lundbeck A/S Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.10.5 H. Lundbeck A/S Recent Developments
11.11 Cellectis SA
11.11.1 Cellectis SA Company Details
11.11.2 Cellectis SA Business Overview
11.11.3 Cellectis SA Repeat Expansion Disorders Treatment Introduction
11.11.4 Cellectis SA Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.11.5 Cellectis SA Recent Developments
11.12 Bio-Techne
11.12.1 Bio-Techne Company Details
11.12.2 Bio-Techne Business Overview
11.12.3 Bio-Techne Repeat Expansion Disorders Treatment Introduction
11.12.4 Bio-Techne Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.12.5 Bio-Techne Recent Developments
11.13 GlaxoSmithKline plc
11.13.1 GlaxoSmithKline plc Company Details
11.13.2 GlaxoSmithKline plc Business Overview
11.13.3 GlaxoSmithKline plc Repeat Expansion Disorders Treatment Introduction
11.13.4 GlaxoSmithKline plc Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.13.5 GlaxoSmithKline plc Recent Developments
11.14 Allergan Aurobindo Pharma Ltd.
11.14.1 Allergan Aurobindo Pharma Ltd. Company Details
11.14.2 Allergan Aurobindo Pharma Ltd. Business Overview
11.14.3 Allergan Aurobindo Pharma Ltd. Repeat Expansion Disorders Treatment Introduction
11.14.4 Allergan Aurobindo Pharma Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.14.5 Allergan Aurobindo Pharma Ltd. Recent Developments
11.15 Sun Pharmaceutical Industries Ltd.
11.15.1 Sun Pharmaceutical Industries Ltd. Company Details
11.15.2 Sun Pharmaceutical Industries Ltd. Business Overview
11.15.3 Sun Pharmaceutical Industries Ltd. Repeat Expansion Disorders Treatment Introduction
11.15.4 Sun Pharmaceutical Industries Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.15.5 Sun Pharmaceutical Industries Ltd. Recent Developments
11.16 Torrent Pharmaceuticals Ltd.
11.16.1 Torrent Pharmaceuticals Ltd. Company Details
11.16.2 Torrent Pharmaceuticals Ltd. Business Overview
11.16.3 Torrent Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Introduction
11.16.4 Torrent Pharmaceuticals Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.16.5 Torrent Pharmaceuticals Ltd. Recent Developments
11.17 Intas Pharmaceuticals Ltd.
11.17.1 Intas Pharmaceuticals Ltd. Company Details
11.17.2 Intas Pharmaceuticals Ltd. Business Overview
11.17.3 Intas Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Introduction
11.17.4 Intas Pharmaceuticals Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.17.5 Intas Pharmaceuticals Ltd. Recent Developments
11.18 Cipla Ltd
11.18.1 Cipla Ltd Company Details
11.18.2 Cipla Ltd Business Overview
11.18.3 Cipla Ltd Repeat Expansion Disorders Treatment Introduction
11.18.4 Cipla Ltd Revenue in Repeat Expansion Disorders Treatment Business (2017-2022)
11.18.5 Cipla Ltd Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
Table 1. Global Repeat Expansion Disorders Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Oral
Table 3. Key Players of Injection
Table 4. Global Repeat Expansion Disorders Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Repeat Expansion Disorders Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Repeat Expansion Disorders Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Repeat Expansion Disorders Treatment Market Share by Region (2017-2022)
Table 8. Global Repeat Expansion Disorders Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Repeat Expansion Disorders Treatment Market Share by Region (2023-2028)
Table 10. Repeat Expansion Disorders Treatment Market Trends
Table 11. Repeat Expansion Disorders Treatment Market Drivers
Table 12. Repeat Expansion Disorders Treatment Market Challenges
Table 13. Repeat Expansion Disorders Treatment Market Restraints
Table 14. Global Repeat Expansion Disorders Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Repeat Expansion Disorders Treatment Revenue Share by Players (2017-2022)
Table 16. Global Top Repeat Expansion Disorders Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Repeat Expansion Disorders Treatment as of 2021)
Table 17. Ranking of Global Top Repeat Expansion Disorders Treatment Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Repeat Expansion Disorders Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Repeat Expansion Disorders Treatment Product Solution and Service
Table 21. Date of Enter into Repeat Expansion Disorders Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Repeat Expansion Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Repeat Expansion Disorders Treatment Revenue Market Share by Type (2017-2022)
Table 25. Global Repeat Expansion Disorders Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Repeat Expansion Disorders Treatment Revenue Market Share by Type (2023-2028)
Table 27. Global Repeat Expansion Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Repeat Expansion Disorders Treatment Revenue Share by Application (2017-2022)
Table 29. Global Repeat Expansion Disorders Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Repeat Expansion Disorders Treatment Revenue Share by Application (2023-2028)
Table 31. North America Repeat Expansion Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Repeat Expansion Disorders Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Repeat Expansion Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Repeat Expansion Disorders Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Repeat Expansion Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Repeat Expansion Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Repeat Expansion Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Repeat Expansion Disorders Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Repeat Expansion Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Repeat Expansion Disorders Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Repeat Expansion Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Repeat Expansion Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Repeat Expansion Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Repeat Expansion Disorders Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Repeat Expansion Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Repeat Expansion Disorders Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Repeat Expansion Disorders Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Repeat Expansion Disorders Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Repeat Expansion Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Repeat Expansion Disorders Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Repeat Expansion Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Repeat Expansion Disorders Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Repeat Expansion Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Repeat Expansion Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Repeat Expansion Disorders Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Repeat Expansion Disorders Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Repeat Expansion Disorders Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Repeat Expansion Disorders Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Repeat Expansion Disorders Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Repeat Expansion Disorders Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 61. Pfizer, Inc. Company Details
Table 62. Pfizer, Inc. Business Overview
Table 63. Pfizer, Inc. Repeat Expansion Disorders Treatment Product
Table 64. Pfizer, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 65. Pfizer, Inc. Recent Developments
Table 66. CRISPR Therapeutics Company Details
Table 67. CRISPR Therapeutics Business Overview
Table 68. CRISPR Therapeutics Repeat Expansion Disorders Treatment Product
Table 69. CRISPR Therapeutics Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 70. CRISPR Therapeutics Recent Developments
Table 71. Acorda Therapeutics Company Details
Table 72. Acorda Therapeutics Business Overview
Table 73. Acorda Therapeutics Repeat Expansion Disorders Treatment Product
Table 74. Acorda Therapeutics Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 75. Acorda Therapeutics Recent Developments
Table 76. Capsida Biotherapeutics Inc. Company Details
Table 77. Capsida Biotherapeutics Inc. Business Overview
Table 78. Capsida Biotherapeutics Inc. Repeat Expansion Disorders Treatment Product
Table 79. Capsida Biotherapeutics Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 80. Capsida Biotherapeutics Inc. Recent Developments
Table 81. Larimar Therapeutics, Inc. Company Details
Table 82. Larimar Therapeutics, Inc. Business Overview
Table 83. Larimar Therapeutics, Inc. Repeat Expansion Disorders Treatment Product
Table 84. Larimar Therapeutics, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 85. Larimar Therapeutics, Inc. Recent Developments
Table 86. Healx, Intellia Therapeutics, Inc. Company Details
Table 87. Healx, Intellia Therapeutics, Inc. Business Overview
Table 88. Healx, Intellia Therapeutics, Inc. Repeat Expansion Disorders Treatment Product
Table 89. Healx, Intellia Therapeutics, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 90. Healx, Intellia Therapeutics, Inc. Recent Developments
Table 91. Editas Medicine Company Details
Table 92. Editas Medicine Business Overview
Table 93. Editas Medicine Repeat Expansion Disorders Treatment Product
Table 94. Editas Medicine Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 95. Editas Medicine Recent Developments
Table 96. Bluebird bio, Inc. Company Details
Table 97. Bluebird bio, Inc. Business Overview
Table 98. Bluebird bio, Inc. Repeat Expansion Disorders Treatment Product
Table 99. Bluebird bio, Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 100. Bluebird bio, Inc. Recent Developments
Table 101. Sanofi, Merck & Co., Inc. Company Details
Table 102. Sanofi, Merck & Co., Inc. Business Overview
Table 103. Sanofi, Merck & Co., Inc. Repeat Expansion Disorders Treatment Product
Table 104. Sanofi, Merck & Co., Inc. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 105. Sanofi, Merck & Co., Inc. Recent Developments
Table 106. H. Lundbeck A/S Company Details
Table 107. H. Lundbeck A/S Business Overview
Table 108. H. Lundbeck A/S Repeat Expansion Disorders Treatment Product
Table 109. H. Lundbeck A/S Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 110. H. Lundbeck A/S Recent Developments
Table 111. Cellectis SA Company Details
Table 112. Cellectis SA Business Overview
Table 113. Cellectis SA Repeat Expansion Disorders Treatment Product
Table 114. Cellectis SA Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 115. Cellectis SA Recent Developments
Table 116. Bio-Techne Company Details
Table 117. Bio-Techne Business Overview
Table 118. Bio-Techne Repeat Expansion Disorders Treatment Product
Table 119. Bio-Techne Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 120. Bio-Techne Recent Developments
Table 121. GlaxoSmithKline plc Company Details
Table 122. GlaxoSmithKline plc Business Overview
Table 123. GlaxoSmithKline plc Repeat Expansion Disorders Treatment Product
Table 124. GlaxoSmithKline plc Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 125. GlaxoSmithKline plc Recent Developments
Table 126. Allergan Aurobindo Pharma Ltd. Company Details
Table 127. Allergan Aurobindo Pharma Ltd. Business Overview
Table 128. Allergan Aurobindo Pharma Ltd. Repeat Expansion Disorders Treatment Product
Table 129. Allergan Aurobindo Pharma Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 130. Allergan Aurobindo Pharma Ltd. Recent Developments
Table 131. Sun Pharmaceutical Industries Ltd. Company Details
Table 132. Sun Pharmaceutical Industries Ltd. Business Overview
Table 133. Sun Pharmaceutical Industries Ltd. Repeat Expansion Disorders Treatment Product
Table 134. Sun Pharmaceutical Industries Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 135. Sun Pharmaceutical Industries Ltd. Recent Developments
Table 136. Torrent Pharmaceuticals Ltd. Company Details
Table 137. Torrent Pharmaceuticals Ltd. Business Overview
Table 138. Torrent Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Product
Table 139. Torrent Pharmaceuticals Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 140. Torrent Pharmaceuticals Ltd. Recent Developments
Table 141. Intas Pharmaceuticals Ltd. Company Details
Table 142. Intas Pharmaceuticals Ltd. Business Overview
Table 143. Intas Pharmaceuticals Ltd. Repeat Expansion Disorders Treatment Product
Table 144. Intas Pharmaceuticals Ltd. Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 145. Intas Pharmaceuticals Ltd. Recent Developments
Table 146. Cipla Ltd Company Details
Table 147. Cipla Ltd Business Overview
Table 148. Cipla Ltd Repeat Expansion Disorders Treatment Product
Table 149. Cipla Ltd Revenue in Repeat Expansion Disorders Treatment Business (2017-2022) & (US$ Million)
Table 150. Cipla Ltd Recent Developments
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Repeat Expansion Disorders Treatment Market Share by Type: 2021 VS 2028
Figure 2. Oral Features
Figure 3. Injection Features
Figure 4. Global Repeat Expansion Disorders Treatment Market Share by Application: 2021 VS 2028
Figure 5. Hospital Pharmacies Case Studies
Figure 6. Retail Pharmacies Case Studies
Figure 7. Online Pharmacies Case Studies
Figure 8. Repeat Expansion Disorders Treatment Report Years Considered
Figure 9. Global Repeat Expansion Disorders Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 10. Global Repeat Expansion Disorders Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Repeat Expansion Disorders Treatment Market Share by Region: 2021 VS 2028
Figure 12. Global Repeat Expansion Disorders Treatment Market Share by Players in 2021
Figure 13. Global Top Repeat Expansion Disorders Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Repeat Expansion Disorders Treatment as of 2021)
Figure 14. The Top 10 and 5 Players Market Share by Repeat Expansion Disorders Treatment Revenue in 2021
Figure 15. North America Repeat Expansion Disorders Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 16. North America Repeat Expansion Disorders Treatment Market Size Market Share by Type (2017-2028)
Figure 17. North America Repeat Expansion Disorders Treatment Market Size Market Share by Application (2017-2028)
Figure 18. North America Repeat Expansion Disorders Treatment Market Size Share by Country (2017-2028)
Figure 19. United States Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Repeat Expansion Disorders Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 22. Europe Repeat Expansion Disorders Treatment Market Size Market Share by Type (2017-2028)
Figure 23. Europe Repeat Expansion Disorders Treatment Market Size Market Share by Application (2017-2028)
Figure 24. Europe Repeat Expansion Disorders Treatment Market Size Share by Country (2017-2028)
Figure 25. Germany Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. France Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. U.K. Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Italy Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Russia Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Nordic Countries Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Repeat Expansion Disorders Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 32. Asia Pacific Repeat Expansion Disorders Treatment Market Size Market Share by Type (2017-2028)
Figure 33. Asia Pacific Repeat Expansion Disorders Treatment Market Size Market Share by Application (2017-2028)
Figure 34. Asia Pacific Repeat Expansion Disorders Treatment Market Size Share by Region (2017-2028)
Figure 35. China Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Japan Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. South Korea Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Southeast Asia Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. India Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Australia Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Repeat Expansion Disorders Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 42. Latin America Repeat Expansion Disorders Treatment Market Size Market Share by Type (2017-2028)
Figure 43. Latin America Repeat Expansion Disorders Treatment Market Size Market Share by Application (2017-2028)
Figure 44. Latin America Repeat Expansion Disorders Treatment Market Size Share by Country (2017-2028)
Figure 45. Mexico Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Brazil Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Middle East & Africa Repeat Expansion Disorders Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 48. Middle East and Africa Repeat Expansion Disorders Treatment Market Size Market Share by Type (2017-2028)
Figure 49. Middle East and Africa Repeat Expansion Disorders Treatment Market Size Market Share by Application (2017-2028)
Figure 50. Middle East and Africa Repeat Expansion Disorders Treatment Market Size Share by Country (2017-2028)
Figure 51. Turkey Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Saudi Arabia Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. UAE Repeat Expansion Disorders Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Pfizer, Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 55. CRISPR Therapeutics Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 56. Acorda Therapeutics Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 57. Capsida Biotherapeutics Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 58. Larimar Therapeutics, Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 59. Healx, Intellia Therapeutics, Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 60. Editas Medicine Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 61. Bluebird bio, Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 62. Sanofi, Merck & Co., Inc. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 63. H. Lundbeck A/S Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 64. Cellectis SA Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 65. Bio-Techne Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 66. GlaxoSmithKline plc Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 67. Allergan Aurobindo Pharma Ltd. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 68. Sun Pharmaceutical Industries Ltd. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 69. Torrent Pharmaceuticals Ltd. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 70. Intas Pharmaceuticals Ltd. Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 71. Cipla Ltd Revenue Growth Rate in Repeat Expansion Disorders Treatment Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed